|
Phenylephrine Clinical Trials
4 actively recruiting trials across 3 locations
Also known as: Neo-Synephrine, Neosynephrine
Pipeline
Phase 4: 3
Top Sponsors
- University of Chicago1
- University of California, San Francisco1
- Thomas Jefferson University1
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital1
Indications
- Heart Disease3
- Diabetes2
- Vasopressor1
- Acute Kidney Injury (AKI)1
- Noncardiac Surgery1
Other1 trial
San Francisco, California1 trial
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
University of California, San Francisco
Phase 4
Chicago, Illinois1 trial
Vasoactive Drugs in Intensive Care Unit
University of Chicago Medical Center
Phase 4
Philadelphia, Pennsylvania1 trial
Low Dose Vasopressin vs Phenylephrine in Cardiac Surgery
Thomas Jefferson Univesity
Phase 4
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.